课题基金 / 基金详情

CLINICAL TRIAL: METFORMIN MITIGATION OF ANTIPSYCHOTIC-INDUCED METABOLIC DYSREGUL

CLINICAL TRIAL: METFORMIN MITIGATION OF ANTIPSYCHOTIC-INDUCED METABOLIC DYSREGUL
临床试验:二甲双胍缓解抗精神病药引起的代谢失调
批准号:
7716877
负责人:
Linmarie Sikich
金额:
$0.05万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-02 至 2008-05-31

项目摘要

项目成果

Linmarie Sikich的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是众多研究子项目之一
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study will evaluate metformin, an oral antihyperglycemic agent, for the prevention of metabolic and physiological changes associated with the use of antipsychotics. We will recruit 40 children and adolescents with a serious pervasive mental illness (SPMI) that have a history of minimal exposure to 2nd generation antipsychotic (SGA) medication. Participants will receive 12 weeks of treatment with either both metformin and the newly initiated SGA, or only the newly initiated SGA. All subjects will receive healthy lifestyle guidance at each visit.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of combined medication and behavioral treatment in young children with comorbid ASD and ADHD
  • 批准号:
    10227713
  • 项目类别:
  • 资助金额:
    $50.59万
  • 财政年份:
    2017
  • 负责人:
    Linmarie Sikich
  • 依托单位:
Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors (SOARS-B)
  • 批准号:
    9121385
  • 项目类别:
  • 资助金额:
    $170.86万
  • 财政年份:
    2012
  • 负责人:
    Linmarie Sikich
  • 依托单位:
Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors (SOARS-B)
Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors (SOARS-B)
海外基金